This inventor holds 5 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents. Top assignees: Bayer Schering Pharma Ag, Bayer Intellectual Property Gmbh. Active years: 2010-2014.
Location History:
- Leverkusen, DE (2012)
- Willich, DE (2010 - 2014)
Company Filing History:
Years Active: 2010-2014
Title: Jan-Olav Henck: Innovator in Medicinal Chemistry
Introduction
Jan-Olav Henck is a notable inventor based in Willich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of medicaments. With a total of 5 patents to his name, Henck has established himself as a key figure in pharmaceutical innovation.
Latest Patents
Among his latest patents, Henck has focused on the production of medicaments containing vardenafil hydrochloride trihydrate. His invention relates to a method for producing these medicaments in solid form, which can be obtained through his innovative processes. This work highlights his commitment to advancing therapeutic options in the pharmaceutical industry.
Career Highlights
Henck has had a distinguished career, working with prominent companies such as Bayer Schering Pharma AG and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to refine his expertise in medicinal chemistry and patent development.
Collaborations
Throughout his career, Henck has collaborated with talented individuals, including Venkata-Rangarao Kanikanti and Roland Rupp. These partnerships have contributed to the success of his projects and the advancement of his inventions.
Conclusion
Jan-Olav Henck's contributions to medicinal chemistry and his innovative patents demonstrate his dedication to improving healthcare solutions. His work continues to influence the pharmaceutical industry and inspire future innovations.